UAE vs. myomectomy for uterine fibroids

Article

In a multicenter comparative study involving 149 women undergoing uterine artery embolization (UAE) and 60 women undergoing myomectomy, researchers found that both procedures resulted in similar bleeding improvement, uterine volume reduction, uterine fibroid quality-of-life score improvement, and overall quality-of-life score improvement.

In a multicenter comparative study involving 149 women undergoing uterine artery embolization (UAE) and 60 women undergoing myomectomy, researchers found that both procedures resulted in similar bleeding improvement, uterine volume reduction, uterine fibroid quality-of-life score improvement, and overall quality-of-life score improvement.

However, the mean hospital stay for the women receiving UAE was 1 day versus 2.5 days for the myomectomy patients. Time to return to normal activities was 15 days for the UAE group versus 44 days for the myomectomy group, and time to return to work was 10 and 37 days, respectively. At least one adverse event occurred in almost twice as many women receiving myomectomy as in those receiving UAE (40.1% vs. 22.1%, respectively).

But benefits must always be weighed against failures, and researchers in a separate retrospective study calculated a 9.4% failure rate for uterine artery embolization.

The symptoms most often prompting subsequent surgery were recurrent menorrhagia, which occurred in 13 (59.1%) of the women, and persistent abdominal pain, which occurred in five (22.7%) of the women.

Goodwin SC, Bradley LD, Lipman JC, et al. Uterine artery embolization versus myomectomy: a multicenter comparative study. Fertil Steril. 2006;85:14-21.

Huang JY, Kafy S, Dugas A, et al. Failure of uterine fibroid embolization. Fertil Steril. 2006;85:30-35.

Recent Videos
March of Dimes 2024 Report highlights preterm birth crisis | Image Credit: marchofdimes.org
Understanding and managing postpartum hemorrhage: Insights from Kameelah Phillips, MD | Image Credit: callawomenshealth.com
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Christie Hilton, DO, discusses breast cancer management | Image Credit: findcare.ahn.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Mammograms may reveal hidden cardiovascular risks, study finds | Image Credit: providers.ucsd.edu
Related Content
© 2024 MJH Life Sciences

All rights reserved.